Biomedical and Biotechnological Sciences

Fidia Farmaceutici S.p.A. is an Italian pharmaceutical company that carries out R&D, production, marketing and sales activities internally. It operates all over the world with the aim of developing and marketing innovative health products based mainly on hyaluronic acid and derivatives. It invests 3.5% of its turnover in R&D and has a global portfolio of over 1,300 patents. The Noto Local Unit occupies about 6,000 square meters with R&D, biology, microbiology, molecular and analytical biology laboratories.

ECLAT S.r.l. is a research based company with a high technological content specialized in the sector of combustion-free devices that can replace the traditional cigarette with clear benefits for health. Established in July 2018 as a spin off of the University of Catania, on the proposal of Prof. Riccardo Polosa, within the Department of Clinical and Experimental Medicine, ECLAT was born from the desire to enhance, concentrate and harmonize skills and professionalism that have developed in the academic, regulatory and industrial fields on the topic of cigarette smoking risk reduction.

Vera Salus Ricerca S.r.l. (VSR) is a biotechnology discovery company specialized in translational biomedical research aimed at the development of innovative drugs for the treatment of human diseases, with a particular focus on incurable diseases. VSR has also devised a new business model that is based on the technological transfer of ownership through innovative development paths, tailor-made for each type of company-client in the biotech world, with the aim of creating new products or processes that increase them. competitiveness on the market strongly.

Materia Nova, R&D center located in Mons, is recognized as a technological accelerator of sustainable innovations in the field of new materials and processes.

OUR SERVICES

Materia Nova's approach is based on open and collaborative innovation articulated around five services :
• Materials and Processes conception and innovation • Equipment Design and Process Upscaling • Analysis and Characterization
• Life Cycle Thinking
• Project Development and Management

OUR TECHNOLOGIES AND SOLUTIONS

Ahead Together
We unite science, technology and talent to get ahead of disease together. We are committed to doing the right thing and we aim to positively impact the health of 2.5 billion people by the end of 2030. We’ll do this by bringing together outstanding people and doing work that matters in an inclusive environment, so we can make an impact on a global scale.

The University Hospital Center "Ambroise Paré", a public general hospital located in Mons, offers a wide range of inpatient and outpatient care and services, both general and specialized, for adults and children. In order to offer the population of Mons-Borinage the most complete care structure possible, the CHU Ambroise Paré also develops its activities through several day hospitals, medico-technical services and specialized consultations.

https://jobs.baxter.com/search-jobs/Lessines/152/4/2802361-3337387-2796741-2786419-2792568-2792567/50x71104/3x83579/5/2

AnaTox is a software and service company for maintenance and qualification of LC/GC/MS instruments established in 2004. The main topic is the development and sup-port of automated qualification tools and software for chromatographic equipment. AnaTox provides consulting and certification of users, operators and admins for qualification purposes. The main product is the AIQ-Tool® software that automates and makes qualification independent from the customer CDS (chromatographic data system). Ana-Tox provide software solutions for manufacturer, service provider and customers.